Preeclampsia: Symptoms, Risks, Pathophysiology, and Management
Preeclampsia is a hypertensive disorder of pregnancy defined by new-onset hypertension (≥140/90 mmHg) after 20 weeks' gestation accompanied by proteinuria (≥300 mg/24h or protein/creatinine ratio ≥0.3) or other signs of end-organ dysfunction (thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema, cerebral/visual symptoms).
Maternal and Fetal Risks
- Preterm birth (iatrogenic or spontaneous) and low birth weight.
- Eclampsia: Generalized tonic-clonic seizures—obstetric emergency.
- HELLP syndrome: Hemolysis, Elevated Liver enzymes, Low Platelets—severe variant.
- Placental abruption: Premature separation → fetal distress, maternal hemorrhage.
- Fetal growth restriction (IUGR) and stillbirth from placental insufficiency.
- Long-term maternal risk: 2-4× increased lifetime cardiovascular disease (hypertension, ischemic heart disease, stroke).
Pathophysiology: The Placental Connection
Preeclampsia originates from abnormal trophoblast invasion and spiral artery remodeling in early pregnancy (first trimester). Inadequate conversion of high-resistance spiral arteries to low-resistance uteroplacental vessels leads to:
- Placental hypoxia/ischemia and oxidative stress.
- Release of anti-angiogenic factors (sFlt-1, soluble endoglin) into maternal circulation.
- Systemic endothelial dysfunction → vasoconstriction, capillary leak, coagulation activation, inflammation.
- Clinical syndrome: hypertension, proteinuria, end-organ involvement.
Management Strategies
Expectant Management (Preterm, Stable)
- Close maternal-fetal surveillance: BP monitoring, labs (CBC, LFTs, creatinine, uric acid), fetal growth/well-being (NST, BPP, Doppler).
- Antihypertensives for severe-range BP (≥160/110): labetalol, nifedipine, methyldopa.
- Corticosteroids (betamethasone) for fetal lung maturity if <34 weeks.
- Magnesium sulfate for seizure prophylaxis if severe features or during delivery.
Definitive Treatment: Delivery
- ≥37 weeks: Delivery recommended.
- 34-36+6 weeks: Delivery if severe features or maternal/fetal instability; otherwise individualized.
- <34 weeks: Expectant management if stable; delivery for severe features, fetal compromise, or 34 weeks reached.
Postpartum Care
- Preeclampsia can develop or worsen postpartum (up to 6 weeks).
- BP monitoring, magnesium continuation (24h postpartum if given), antihypertensive titration.
- Cardiovascular risk counseling and long-term follow-up.
Multidisciplinary care (OB, MFM, nephrology, cardiology, neonatology) optimizes outcomes. Patient education on warning signs (severe headache, visual changes, epigastric pain, sudden swelling) empowers timely reporting. Preeclampsia remains a leading cause of maternal and perinatal morbidity—vigilance saves lives.
Genetic Disorders - Related Articles
- Understanding Proliferative Retinopathy: Causes, Complications & Treatment
- The Importance of Donated Plasma: Life-Saving Therapies Explained
- Nebulizers and Denufosol: Enhancing Medication Delivery for Cystic Fibrosis
- Understanding mRNA, tRNA, and rRNA: The Building Blocks of Protein Synthesis
- Growth Disorders in Children: Types, Causes, and Treatment Approaches
- Blood Type Inheritance: Can Two Type O Parents Have a Type A Child?
- Transmural Defect: Definition, Locations, Causes, and Examples
